Biomedical Engineering Reference
In-Depth Information
59. Kuroda, M., Kusuhara, H., Endou, H. and Sugiyama, Y. (2005). Rapid elimination of
cefaclor from the cerebrospinal fluid is mediated by a benzylpenicillin-sensitive mechanism
distinct from organic anion transporter 3. J Pharmacol Exp Ther 314, 855-861.
60. Hosoya, K., Tetsuka, K., Nagase, K., Tomi, M., Saeki, S., Ohtsuki, S., Takanaga, H.,
Yanai, N., Obinata, M., Kikuchi, A., Okano, T. and Terasaki, T. (2000). Conditionally
immortalized brain capillary endothelial cell lines established from a transgenic mouse
harboring temperature-sensitive simian virus 40 large T-antigen gene. AAPS PharmSci 2,
E27.
61. Hosoya, K.I., Takashima, T., Tetsuka, K., Nagura, T., Ohtsuki, S., Takanaga, H., Ueda,
M., Yanai, N., Obinata, M. and Terasaki, T. (2000). mRna expression and transport
characterization of conditionally immortalized rat brain capillary endothelial cell lines; a
new in vitro BBB model for drug targeting. J Drug Target 8, 357-370.
62. Terasaki, T., Ohtsuki, S., Hori, S., Takanaga, H., Nakashima, E. and Hosoya, K. (2003).
New approaches to in vitro models of blood-brain barrier drug transport. Drug Discov
Today 8, 944-954.
63. Hino, T., Yokota, T., Ito, S., Nishina, K., Kang, Y.S., Mori, S., Hori, S., Kanda, T.,
Terasaki, T. and Mizusawa, H. (2006). In vivo delivery of small interfering RNA targeting
brain capillary endothelial cells. Biochem Biophys Res Commun 340, 263-267.
64. Taipalensuu, J., Tornblom, H., Lindberg, G., Einarsson, C., Sjoqvist, F., Melhus, H.,
Garberg, P., Sjostrom, B., Lundgren, B. and Artursson, P. (2001). Correlation of gene
expression of ten drug efflux proteins of the ATP-binding cassette transporter family
in normal human jejunum and in human intestinal epithelial Caco-2 cell monolayers. J
Pharmacol Exp Ther 299, 164-170.
65. Englund, G., Rorsman, F., Ronnblom, A., Karlbom, U., Lazorova, L., Grasjo, J.,
Kindmark, A. and Artursson, P. (2006). Regional levels of drug transporters along the
human intestinal tract: Co-expression of ABC and SLC transporters and comparison with
Caco-2 cells. Eur J Pharm Sci 29, 269-277.
66. Chong, S., Dando, S.A., Soucek, K.M. and Morrison, R.A. (1996). In vitro permeability
through caco-2 cells is not quantitatively predictive of in vivo absorption for peptide-like
drugs absorbed via the dipeptide transporter system. Pharm Res 13, 120-123.
67. Balimane, P.V., Han, Y.H. and Chong, S. (2006). Current industrial practices of assessing
permeability and P-glycoprotein interaction. AAPS J 8, E1-E13.
68. Balimane, P.V. and Chong, S. (2005). Cell culture-based models for intestinal permeability:
a critique. Drug Discov Today 10, 335-343.
69. Adachi, Y., Suzuki, H. and Sugiyama, Y. (2003). Quantitative evaluation of the function
of small intestinal P-glycoprotein: comparative studies between in situ and in vitro. Pharm
Res 20, 1163-1169.
70. Watanabe, T., Onuki, R., Yamashita, S., Taira, K. and Sugiyama, Y. (2005). Construction
of a functional transporter analysis system using MDR1 knockdown Caco-2 cells. Pharm
Res 22, 1287-1293.
71. Dresser, G.K., Bailey, D.G., Leake, B.F., Schwarz, U.I., Dawson, P.A., Freeman, D.J. and
Kim, R.B. (2002). Fruit juices inhibit organic anion transporting polypeptide-mediated
drug uptake to decrease the oral availability of fexofenadine. Clin Pharmacol Ther 71,
11-20.
72. Kamath, A.V., Yao, M., Zhang, Y. and Chong, S. (2005). Effect of fruit juices on the oral
bioavailability of fexofenadine in rats. J Pharm Sci 94, 233-239.
Search WWH ::
Custom Search